As far as I am aware, the answer to the original question is a no.
Australia uses evidence based practice. Meaning anything done by a healthcare professional SHOULD always be able to fall back onto research to justify their actions.
Therefore a GP would be taking one hell of a risk by prescribing a drug meant for one use, for another, without the backing of research to suggest its appropriate.
Happy to be proven wrong, but I'm fairly confident its a no, that would defeat the entire purpose of doing all of these studies in the first place if a GP could go "hmmm lets have a go at using Ventolin to cure athletes foot, it might work, lets have a crack"
- Forums
- ASX - By Stock
- NEU
- Application
Application, page-15
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$20.17 |
Change
0.070(0.35%) |
Mkt cap ! $2.578B |
Open | High | Low | Value | Volume |
$20.39 | $20.53 | $20.14 | $4.102M | 202.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 249 | $20.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.31 | 790 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 249 | 20.150 |
2 | 815 | 20.110 |
1 | 99 | 20.100 |
1 | 912 | 20.090 |
1 | 790 | 20.070 |
Price($) | Vol. | No. |
---|---|---|
20.310 | 790 | 1 |
20.350 | 790 | 1 |
20.390 | 1640 | 2 |
20.420 | 790 | 1 |
20.580 | 2400 | 1 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |